End the duopoly

Healthcare is in the midst of a ‘paradigm shift’

Good morning.

Will the pandemic lead to a revolution in health care science?

That was the tantalizing possibility I took away from day one of Fortune Brainstorm Health. This was our first-ever all-virtual conference, and it demonstrated the amazing possibilities of the format. The team, lead by Fortune Editor-in-Chief Clifton Leaf, assembled a Who’s Who of health care leaders—on one platform, if not in one place—for a fascinating day of discussions about the future.

Many of the participants emphasized the extraordinary cooperation the pandemic has prompted in health science—something that I’ve written about here before. “We are all on various collaborations together,” said Novartis CEO Vas Narasimhan. “An unprecedented level of cooperation between institutions of business, government, academia, and institutions like the NIH,” said Bristol Meyer Squibb CEO Giovanni Caforio. “Lots of shots on goal,” said Amgen CEO Robert Broadway.

I’ve assumed that the unusual spasm of Pharma cooperation would pass with the pandemic. But Caforio argued otherwise. “My hope is this will be a galvanizing moment,” he said. “What we have learned is to work collaboratively like never before, to challenge our thinking, and to accelerate the drug development process. We have done things in six months that would have taken five […]

Related Posts
1 of 1,130

read more here —> fortune.com

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More